Publication | Closed Access

Liraglutide, a glucagon-like peptide-1 receptor agonist, facilitates osteogenic proliferation and differentiation in MC3T3-E1 cells through phosphoinositide 3-kinase (PI3K)/protein kinase B (AKT), extracellular signal-related kinase (ERK)1/2, and cAMP/protein kinase A (PKA) signaling pathways involving β-catenin

Mc3t3-e1 CellsExtracellular Signal-related KinaseSignal TransductionMolecular PhysiologySignaling PathwayMedicineBone HomeostasisPharmacologyCell BiologyCell SignalingCellular PhysiologyOsteocalcin/Protein Kinase BMolecular Signaling